Topiramate Tablet, Film Coated
Product Images NDC 68788-7460

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-7460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Chemical structure diagram of topiramate, showing its molecular arrangement including rings, oxygen atoms, methyl groups, and a sulfonamide group. The structure highlights the stereochemistry with dashed and solid wedges for specific bonds.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
A line graph showing cumulative rates for time to first seizure over a period of 500 days. Two groups are compared: Topiramate 50 mg/day and Topiramate 400 mg/day, with cumulative rates plotted against time in days. The graph includes a p-value of 0.0002, indicating a statistical comparison between the two dosage groups.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
Bar chart showing change from baseline to double-blind phase in average monthly migraine period rate for placebo and topiramate doses (50 mg/day, 100 mg/day, 200 mg/day) in two studies (Study 11 and Study 12). The x-axis lists treatment groups with sample sizes. The y-axis measures change in migraine rate, with bars indicating mean changes and error bars for standard error. Statistical significance is noted with asterisks below select bars.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 04

7ea951b6 B020 481f 8acc 12fb7a3a69fd 04
Label for Topiramate Tablets 25 mg, a film-coated oral tablet. The label states it is generic for Topamax and manufactured by Zydus Pharmaceuticals USA Inc., with labeling by Preferred Pharmaceuticals, Inc. It includes dosing instructions in English and Spanish advising to take tablets every 12 hours and to avoid alcohol while taking the medication. The label also cautions against transfer of the drug and includes barcode and product code areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.